Search For "technical advisor"
Health has come on political agenda after 70-75 years, says NTAGI chief
Updated : 4 years ago IST
Narmada (Gujarat) [India], May 6 (ANI): National Technical Advisory Group on Immunisation (NTAGI) chief Dr NK Arora on Thursday said that for the first time after 70-75 years, health has come on the political agenda.
Read More
NTAGI recommends COVID-19 precaution dose before 9 months for those flying
Updated : 4 years ago IST
New Delhi [India], May 5 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) has recommended allowing the administration of precautionary doses before nine months for those who are travelling abroad according to the receiving country's needs,
Read More
Adarsh Insulations expands its horizons to contribute towards the economic
Updated : 4 years ago IST
New Delhi [India], May 2 (ANI/ATK): India's leading thermal insulations firm, Adarsh Insulations has been successfully expanding its horizons into different verticals including real estate projects, warehouses construction and service providing, consulting company, technical advisory comp
Read More
NTAGI to review data of COVID-19 vaccines for children aged 5-12 years: So
Updated : 4 years ago IST
New Delhi [India], May 2 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of COVID-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.
Read More
COVID vaccine: Sputnik Light to be given as precaution dose for those vacc
Updated : 4 years ago IST
New Delhi [India], April 30 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources.
Read More
NTAGI approves SII's Covovax COVID vaccine for 12-17 age group: Sources
Updated : 4 years ago IST
New Delhi [India], April 29 (ANI): National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
Read More
COVID-19 variants will keep on occurring, nothing to panic about, says Dr
Updated : 4 years, 1 month ago IST
New Delhi [India], April 11 (ANI): New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India, National Technical Advisory Group on Immunisation (NTAGI), Dr NK Aror
Read More
INSACOG starts sewage water surveillance across 19 sites in 15 states to d
Updated : 4 years, 1 month ago IST
New Delhi [India], April 8 (ANI): With a continuous decline in COVID-19 cases in the country, the Indian Sars-CoV-2 Genomic Consortium (INSACOG) has started surveillance of sewage water at 19 different sites in 15 States to detect the presence of the Sars-CoV-2 virus.
Read More
NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources
Updated : 4 years, 1 month ago IST
New Delhi [India], March 30 (ANI): The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday.
Read More
NTAGI recommends reducing gap between two doses of Covishield: Sources
Updated : 4 years, 2 months ago IST
New Delhi [India], March 20 (ANI): The National Technical Advisory Group on Immunization (NTAGI) on Sunday recommended the Union Ministry of Health to reduce the COVID-19 vaccine Covishield's duration of the second dose to somewhere between 8 to 16 weeks after the first dose in view of the o
Read More
High-risk children are priority of COVID-19 vaccination programme
Updated : 4 years, 2 months ago IST
New Delhi [India], March 15 (ANI): The primary focus was immunisation of children with comorbidities but due to the unavailability of data of such children, we have decided to open immunization for all the children between the age group of 12-15 years, said Dr NK Arora, Chairman of COVID-
Read More
Corbevax COVID vaccine is safe, offers high antibody levels: NTAGI chief
Updated : 4 years, 3 months ago IST
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
Read More